Publicaciones en las que colabora con José A. San Román (25)

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

2021

  1. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  2. Looking for the Most Effective Transcatheter Treatment for Tricuspid Regurgitation: A Long Road

    JACC: Cardiovascular Interventions

  3. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

    Canadian Journal of Cardiology, Vol. 36, Núm. 10, pp. 1624-1632

2018

  1. Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 67-73

  2. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2016

  1. Comentarios a la guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1119-1125

  2. Competencias profesionales y trabajo en equipo en pacientes con enfermedades cardiacas agudas y críticas. Respuesta

    Revista Espanola de Cardiologia

  3. The Healthcare of Patients with Acute and Critical Heart Disease. Position of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 69, Núm. 3, pp. 239-242

2015

  1. Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: A multicenter, prospective, randomized, open-labeled TECAM trial

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2372-2382

2011

  1. Evolución a largo plazo de la función ventricular tras la terapia celular intracoronaria en el infarto agudo de miocardio

    Revista Espanola de Cardiologia, Vol. 64, Núm. 4, pp. 334-337

2010

  1. Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study

    American Heart Journal, Vol. 159, Núm. 6, pp. 1154.e1-1154.e8

  2. Role of the paclitaxel-eluting stent and tirofiban in patients with st-elevation myocardial infarction undergoing postfibrinolysis angioplasty the GRACIA-3 randomized clinical trial

    Circulation: Cardiovascular Interventions, Vol. 3, Núm. 4, pp. 297-307

2009

  1. Análisis cuantitativo de la función ventricular izquierda como herramienta para la investigación clínica. Fundamentos y metodología

    Revista Espanola de Cardiologia, Vol. 62, Núm. 5, pp. 535-551

  2. Comparison of Neointimal Hyperplasia With Drug-Eluting Stents Versus Bare Metal Stents in Patients Undergoing Intracoronary Bone-Marrow Mononuclear Cell Transplantation Following Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 103, Núm. 12, pp. 1651-1656

  3. Prosthetic mitral thrombosis treated with two consecutive fibrinolytic administrations

    Revista Espanola de Cardiologia

2008

  1. Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification

    European Heart Journal, Vol. 29, Núm. 3, pp. 371-376

  2. Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: Un estudio de cardiorresonancia con contraste

    Revista Espanola de Cardiologia, Vol. 61, Núm. 6, pp. 602-610

2007

  1. Bone-marrow-derived cells for cardiac stem cell therapy: Safe or still under scrutiny?

    Nature Clinical Practice Cardiovascular Medicine, Vol. 4, Núm. SUPPL. 1